Динамика изменений стабилометрических параметров у детей с синдромом опсоклонус-миоклонус при проведении различных реабилитационных методик
Аннотация
Об авторах
О. А. ПоляковРоссия
аспирант отделения медицинской реабилитации
119571, Москва, Ленинский пр-т, 117. Тел.: +7 (495) 936-9041
О. А. Лайшева
Россия
Е. С. Ильина
Россия
Б. А. Поляев
Россия
С. А. Парастаев
Россия
Список литературы
1. Gorman M.P. Update on diagnosis, treatment, and prognosis in opsoclonus-myoclonus-ataxia syndrome. Current opinion in pediatrics 2010; 22 (6): 745-50.
2. Pang K.K., et al. A prospective study of the presentation and management of dancing eye syndrome/opsoclonus myoclonus syndrome in the United Kindom. Eur J Pediatr Neurol 2010; 14: 156-61.
3. Herman T.E., Siegel M.J. Ataxia without opsoclonus: right lumbar sympathetic trunk neuroblastoma. Clin Pediatr 2009; 48: 336-40.
4. Krug P., et al. Opsoclonus-myoclonus in children associated or not with neuroblastoma. Eur J Pediatr Neurol 2010; 14: 400-9.
5. Mitchell W.G., et al. Effect of Increased Immunosuppression on Developmental Outcome of Opsoclonus Myoclonus Syndrome (OMS). J Child Neurol 2015; 30 (8): 976-82.
6. Pless M., Ronthal M. Treatment of opsoclonus-myoclonus with high-dose intravenous immunoglobulin. Neurology 1996; 46 (2): 583-4.
7. Krug P., et al. Opsoclonus-myoclonus in children associated or not with neuroblastoma. Eur J Paediatr Neurol 2010; 14 (5): 400-9.
8. Herman T.E., Siegel M.J. Ataxia without opsoclonus: right lumbar sympathetic trunk neuroblastoma. Clin Pediatr (Phila) 2009; 48 (3): 336-40.
9. Rostásy K., et al. High dose pulsatile dexamethasone therapy in children with opsoclonus-myoclonus syndrome. Neuropediatr 2006; 37 (5): 291-5.
10. Kinsbourne M. Myoclonic encephalopathy of infants. J Neurol Neurosurg Psychiatry 1962; 25 (3): 271-6.
11. Boltshauser E., Deonna T., Hirt H.R. Myoclonic encephalopathy of infants or “dancing eyes syndrome”. Report of 7 cases with long-term follow-up and review of the literature (cases with and without neuroblastoma). Helv Pediatr Acta 1979; 34 (2): 119-33.
12. Mitchell W.G., et al. Effect of Increased Immunosuppression on Developmental Outcome of Opsoclonus Myoclonus Syndrome (OMS). J Child Neurol 2015; 30 (8): 976-82.
13. Krasenbrink I., et al. Increased prevalence of autoimmune disorders and autoantibodies in parents of children with opsoclonus-myoclonus syndrome (OMS). Neuropediatr 2007; 38 (3): 114-6.
14. Pranzatelli M.R., et al. Rituximab (anti-CD20) adjunctive therapy for opsoclonus-myoclonus syndrome. J Pedi-atr Hematol Oncol 2006; 28 (9): 585-93.
15. Pranzatelli M.R., et al. Insights on chronic-relapsing opsoclonus-myoclonus from a pilot study of mycophenolate mofetil. J Child Neurol 2009; 24 (3): 316-22.
16. de Grandis E., et al. Long-term follow-up of neuroblastoma-associated opsoclonus-myoclonus-ataxia syndrome. Neuropediatr 2009; 40 (3): 103-11.
17. Upledger J.E. Craniosacral therapy. Phys Ther 1995; 75 (4): 328-30.
Для цитирования:
Поляков О.А., Лайшева О.А., Ильина Е.С., Поляев Б.А., Парастаев С.А. Динамика изменений стабилометрических параметров у детей с синдромом опсоклонус-миоклонус при проведении различных реабилитационных методик. Вопросы гематологии/онкологии и иммунопатологии в педиатрии. 2017;16(3):48-54. https://doi.org/10.24287/1726-1708-2017-16-3-48-54
For citation:
Polyakov O.A., Laisheva O.A., Ilina E.S., Polyaev B.A., Parastaev S.A. Dynamics of the stabilometric parameters in children with the opsoclonus myoclonus syndrome in carrying out various rehabilitation methods. Pediatric Hematology/Oncology and Immunopathology. 2017;16(3):48-54. (In Russ.) https://doi.org/10.24287/1726-1708-2017-16-3-48-54